• Follow I-95 South to US-1 South via Exit 46 toward Boston
• Take exit 37A to merge onto I-93 S / US-1 S
• Take Exit 20A toward South Station and keep right on 20A
• Turn RIGHT at next light onto Summer Street
• Turn RIGHT at first intersection onto High Street; public parking available at 150 Federal on left

• Merge onto I-95 North to I-93 North
• Merge onto I-93 N / US-1 North via Exit 12 toward Boston
• Take Exit 20 towards South Station/I-90 W/Worcester
• Follow signs for Chinatown/South Station
• Turn RIGHT at Kneeland Street
• Kneeland Street turns LEFT and becomes Atlantic Avenue
• Turn LEFT at Summer Street
• Turn RIGHT at High Street
• Turn LEFT at Federal Street
• End at 160 Federal Street

• Start out on Atlantic Avenue (0.1 miles)
• Go LEFT onto Summer Street (0.1 miles)
• Turn RIGHT onto High Street (0.1 miles)
• Turn LEFT onto Federal Street (0.1 miles)
• End at 160 Federal Street, Boston, MA 02110

• Start out on Causeway Street (0.1 miles)
• Cross Causeway Street to Friend Street (0.1 miles)
• Go straight on Friend Street (0.2 miles)
• The end of Friend Street intersects w/ Congress Street (0.1 miles)
• Take a LEFT onto Congress Street (0.1 miles)
• Go straight on Congress Street (0.7 miles)
• Take a RIGHT onto Franklin Street (0.1 miles)
• Take a LEFT onto Federal Street (0.2 miles)
• End at 160 Federal Street, Boston, MA 02110

The Retail Financial Services Practice Group provides transactional, regulatory, compliance, operations, and dispute resolution services to lenders, deposit takers, non-deposit investment providers, and insurance producers.  We also serve vendors who support these types of retail financial service companies (e.g., software companies and loan servicers).  Our clients include local, regional and national financial institutions (including national banks, federal savings banks, federal credit unions, and state-chartered banks, credit unions and industrial loan companies), bank holding companies, credit card companies, nonbank lenders (including mortgage companies, auto finance companies and education loan providers), payroll companies, insurance producers, and bank-affiliated broker/dealers.  We provide both complete state law advice, focusing on Maine, Massachusetts and New Hampshire, and national guidance on both federal law and (as coordinating counsel) other state law matters. 

Our core business is consumer lending, including all aspects of origination or acquisition, maintenance and disposition of consumer assets.  We also deal in nonconsumer retail financial services products, such as business credit cards and commercial cash management and Internet banking services.  The common thread of our marketplace is a regulated service provider delivering a financial service in repeated transactions that must be standardized to be profitable – and (in the case of resulting assets) in order to be saleable in a secondary market.

We help clients succeed by protecting and enforcing their valuable intellectual property rights.

Our Intellectual Property Group deals with all the legal issues relating to patents, trademarks, copyrights and trade secrets. Our clients are big and small, from Fortune 500 companies to brand new start-ups. We handle work on the cutting edge of software, the life sciences, advanced materials processing and high-tech manufacturing.

Clients turn to us for:

Leading academic institutions and biotech companies through-out the United States and abroad, have selected Pierce Atwood to perform their patent, licensing and litigation work. Whether your intellectual property results from work in the area of embryonic stem cell and cloning technology, immunology, medical devices or other work in the life sciences, and whether your needs involve advice concerning a sponsored research or collaboration agreement, or a complex licensing transaction or freedom to operate analysis, to everything in between, Pierce Atwood’s biotech team has the technical expertise and the experience and legal resources to help you. Pierce Atwood biotech team professionals provide advice and strategic counseling to biotech clients on complex licensing transactions, sponsored research, research collaboration and material transfer agreements, as well as advice and counsel on general commercial and transactional work, mergers and acquisitions, complex financing transactions and securities matters. Our biotechnology patent litigation attorneys have represented both inventors and alleged infringers in patent jury trials and have experience with cutting-edge patent matters involving technologies such as chemical compositions, embryonic stem cell and cloning technology. Our biotechnology patent professionals have prosecuted hundreds of patent applications directed toward diagnostic and therapeutic inventions, compositions and methods relating to gene therapy; novel proteins, peptides and nucleic acids; drug delivery compositions and methods; novel nucleic acid regulatory sequences; compositions and methods for modulating the immune response; techniques for the analysis of nucleic acids, and animal models for disease including transgenic and knockout models, and we also have research experience in a wide array of disciplines, including molecular biology, neurobiology, cell biology, biophysics, biochemistry, genetics and chemical synthesis.

We advise writers, producers, directors, and talent in connection with motion pictures, television, and multi-media ventures and contracting matters.  With almost 10 years of experience in the entertainment law arena in Beverly Hills, California, we bring experience and expertise unique in our region to this practice area.  Representative matters include:       

• Representation of an award winning documentary film maker
• Production attorney for independently financed motion pictures
• Representation of producers in connection with the optioning of literary material
• Representation of screenwriters in connection with both work for hire and option negotiations
• Negotiation of film distribution deals